FDA approves first autologous cellularized scaffold for the repair of cartilage defects of the knee - FDA Press Releases

The U.S. Food and Drug Administration today approved Maci (autologous cultured chondrocytes on porcine collagen membrane) for the repair of symptomatic, full-thickness cartilage defects of the knee in adult patients. Maci is the first FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient’s own knee.

from Food and Drug Administration--Press Releases http://ift.tt/2gXDGnQ
via IFTTT